Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 473, doi. 10.1007/s13300-016-0176-9
- By:
- Publication type:
- Article
Works matching IS 18696953 AND DT 2016 AND VI 7 AND IP 3
Results: 18
1
2
Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 483, doi. 10.1007/s13300-016-0177-8
- By:
- Publication type:
- Article
3
Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis.
- Published in:
- 2016
- By:
- Publication type:
- Report
4
Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 411, doi. 10.1007/s13300-016-0180-0
- By:
- Publication type:
- Article
5
Practical Approaches to Diabetes Care: An Introduction.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 377, doi. 10.1007/s13300-016-0186-7
- By:
- Publication type:
- Article
6
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 401, doi. 10.1007/s13300-016-0187-6
- By:
- Publication type:
- Article
7
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus.
- Published in:
- 2016
- By:
- Publication type:
- Report
8
How Much Time Do Families Spend on the Health Care of Children with Diabetes?
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 497, doi. 10.1007/s13300-016-0181-z
- By:
- Publication type:
- Article
9
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 537, doi. 10.1007/s13300-016-0185-8
- By:
- Publication type:
- Article
10
A Practical Approach to Gastrointestinal Complications of Diabetes.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 379, doi. 10.1007/s13300-016-0182-y
- By:
- Publication type:
- Article
11
Cost-Effectiveness Analysis of d-Nav for People with Diabetes at High Risk of Neuropathic Foot Ulcers.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 511, doi. 10.1007/s13300-016-0183-x
- By:
- Publication type:
- Article
12
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 527, doi. 10.1007/s13300-016-0184-9
- By:
- Publication type:
- Article
13
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 439, doi. 10.1007/s13300-016-0189-4
- By:
- Publication type:
- Article
14
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 551, doi. 10.1007/s13300-016-0190-y
- By:
- Publication type:
- Article
15
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 561, doi. 10.1007/s13300-016-0191-x
- By:
- Publication type:
- Article
16
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 591, doi. 10.1007/s13300-016-0192-9
- By:
- Publication type:
- Article
17
Patterns and Impact of Hypoglycemia, Hyperglycemia, and Glucose Variability on Inpatients with Insulin-Treated Cystic Fibrosis-Related Diabetes.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 575, doi. 10.1007/s13300-016-0194-7
- By:
- Publication type:
- Article
18
Population Pharmacokinetics and Exposure-Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2016, v. 7, n. 3, p. 455, doi. 10.1007/s13300-016-0174-y
- By:
- Publication type:
- Article